Pancreatic endocrine tumors

Current Opinion in Oncology

Volumn 13, Issue 1, 2001, Pages 52-56

  Chun, Jonathan ^a   Doherty, Gerard M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GASTRIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOCRINE TUMOR; GASTRINOMA; HUMAN; INSULINOMA; PANCREAS TUMOR; PATHOPHYSIOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIPPLE SYNDROME; SYNDROME DELINEATION; ZOLLINGER ELLISON SYNDROME;

ANTINEOPLASTIC AGENTS; GASTRINOMA; HUMANS; INSULINOMA; LIVER NEOPLASMS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS;

EID: 0035175013     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200101000-00010     Document Type: Review

References (26)

1. Pancreatic endocrine tumors: Recent advances
2. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long, standing Zollinger-Ellison syndrome
3. Surgery to cure the Zollinger-Ellison syndrome
4. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome
5. Neuroglycopenic and other symptoms in patients with insulinomas
6. Preoperative localization of insulinomas is not necessary
7. Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors
8. Role of EUS in the preoperative localization of insulinomas compared with spiral CT
9. Nesidioblastosis with hyperinsulinemic hypoglycema in adults: Report of two cases
10. Adult hyperinsulinemic hypoglycema not caused by insulinoma: A report of two cases
11. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1 (MEN 1)
12. Type 1 multiple endocrine neoplasia (men1): Contribution of genetic analysis to the screening and follow-up of a large french kindred
13. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1
14. A new mutation of the MEN-1 gene in an Italian kindred with multiple endocrine neoplasia type 1
15. Germline mutations in the multiple endocrine neoplasia type 1 gene: Evidence for frequent splicing defects
16. Detection of small, functional islet cell tumors in the pancreas: Selection of MR imaging sequences for optimal sensitivity
17. Specificity of somatostatin receptor in scintigraphy: A prospective study and effects of false-positive localizations on management in patients with gastrinomas
18. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
19. Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: Comparison with other modalities
20. Octreotide improved biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with MEN-1
21. Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR
22. Combination therapy with octreolide and alpha-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors
23. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms
24. Embolization and chemoembolization therapy for neuroendocrine tumors
25. Chemoembolization of hepatic metastases from intestinal neuroendocrine tumours
26. Toxicity of high activity Inoctreotide therapy in patients with disseminated neuroendocrine tumours